Velarion Records
Free. Unsubscribe any time.

Edgewise Therapeutics, Inc. (EWTX)

Edgewise Therapeutics, Inc. filed 11 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 22 transactions and 284,193 shares. 8 carry the SEC's AFF10B5ONE flag; 3 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Edgewise Therapeutics, Inc. 22

Adoption dates in Edgewise Therapeutics, Inc. 3

Results prints in Edgewise Therapeutics, Inc. 0

Trades before a print in Edgewise Therapeutics, Inc. 0

Interval to Edgewise Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Edgewise Therapeutics, Inc. states

Filing text: “10b5-1 Plan adopted by the Reporting Person on September 30, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.